Sign in
EC

EASTMAN CHEMICAL CO (EMN)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 revenue $2.20B (-11% y/y, -4% q/q) with adjusted EPS $1.14, both modestly below Street, as volumes fell on consumer discretionary weakness, tariff-related inventory unwinding, and lower asset utilization; price-cost remained stable in specialties while Chemical Intermediates (CI) spreads compressed .
  • Adjusted EBIT margin compressed to 9.5% from 12.0% in Q2 and 14.9% a year ago on lower utilization to prioritize cash generation; operating cash flow was strong at $402M aided by ~$204M inventory reduction .
  • Management introduced FY25 adjusted EPS guidance of $5.40–$5.65 and now expects FY25 operating cash flow to “approach $1B” (down from ~$1.2B view in April); reiterated >$75M net cost takeout in 2025 and ~$100M additional in 2026 .
  • Circular platform momentum: Kingsport methanolysis operating well; management sees a “meaningful” 2026 EBITDA lift as ARPET and specialty Renew ramp, with 90% yields and a feasible ~30% capacity “bottleneck” expansion; Pepsi baseload contract restructured to pull forward volume into 2026 .
  • Near-term stock catalysts: slight miss vs consensus and lowered OCF framework vs April could pressure shares, while evidence of Q4 destock completion, Q1 rebound, ARPET contract conversions, and cost-down execution are potential upside drivers .

What Went Well and What Went Wrong

What Went Well

  • Cash generation: $402M operating cash flow (vs. $396M y/y), with ~$204M inventory reduction; $146M returned via dividends and buybacks .
  • Price discipline in specialties: price-cost stable despite softer volumes; AFP delivered 17.9% adjusted EBIT margin in Q3 (up vs. 17.5% y/y) .
  • Circular platform execution: Kingsport methanolysis plant running well with 90% yields; management confident in a feasible ~30% capacity expansion via bottlenecking and growing ARPET specialty demand; “meaningful” EBITDA uplift expected next year .
    • “We expect a modest increase in revenue from the Kingsport methanolysis facility” .

-controlled text—

What Went Wrong

  • Demand/volume: Sales -11% y/y on 10% lower volume/mix as consumer discretionary softness and tariff-related inventory unwinding weighed, notably in Advanced Materials and Fibers .
  • Utilization headwinds: EBIT down to $188M (from $329M y/y) with adjusted EBIT margin 9.5% (from 14.9% y/y) given deliberate underutilization to drive cash; CI spreads pressured .
  • Fibers/CI weakness: Fibers sales -24% y/y with lower acetate tow and textiles into China; CI sales -16% y/y on 8% lower volume and 8% lower prices as commodity fundamentals remain unfavorable .

Financial Results

Headline Metrics vs Prior Periods and Estimates

MetricQ3 2024Q2 2025Q3 2025S&P Global Consensus (Q3 2025)
Revenue ($M)$2,464 $2,287 $2,202 $2,275.47*
GAAP EPS ($)$1.53 $1.20 $0.40 —
Adjusted EPS ($)$2.26 $1.60 $1.14 $1.16521*
EBIT ($M)$329 $222 $188 —
Adjusted EBIT ($M)$366 $275 $210 —
Adjusted EBIT Margin (%)14.9% 12.0% 9.5% —
Operating Cash Flow ($M)$396 $233 $402 —

Separate consensus comparison:

  • Revenue: $2.202B vs $2.276B* (miss)
  • Adjusted EPS: $1.14 vs $1.165* (slight miss)
  • EBITDA: $342M* vs $338.3M* (slight beat)

Values marked with * retrieved from S&P Global.

Segment Sales

Segment Sales ($M)Q3 2024Q2 2025Q3 2025
Advanced Materials$787 $777 $728
Additives & Functional Products$744 $769 $716
Chemical Intermediates$593 $463 $499
Fibers$336 $274 $254
Other$4 $4 $5
Total$2,464 $2,287 $2,202

Segment Adjusted EBIT and Margins

Segment (Adj. EBIT, $M)Q3 2024Q2 2025Q3 2025Adj. EBIT Margin Q3 2024Adj. EBIT Margin Q2 2025Adj. EBIT Margin Q3 2025
Advanced Materials$122 $121 $53 15.5% 15.6% 7.3%
Additives & Functional Products$130 $153 $128 17.5% 19.9% 17.9%
Chemical Intermediates$43 ($30) $1 7.3% (6.5%) 0.2%
Fibers$112 $81 $67 33.3% 29.6% 26.4%
Total Adjusted EBIT$366 $275 $210 14.9% 12.0% 9.5%

KPIs

KPIQ3 2024Q3 2025Notes
Operating Cash Flow ($M)$396 $402 Working capital release; ~$204M inventory reduction
Inventory Change ($M)—+$204 improvement Reduction vs Q2 levels
Additions to PPE (Capex, $M)$(120) $(137) Quarterly additions
Cash & Equivalents ($M)$622 $489 Period-end
Net Debt ($M)$4,180 (12/31/24) $4,586 (9/30/25) Includes FX impacts
Capital Returns ($M)—$146 in Q3 (dividends + buybacks) Dividend declared $0.83/share (paid Oct 7)

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Adjusted EPSFY 2025— (moved to quarterly guidance earlier)$5.40–$5.65 New range introduced
Operating Cash FlowFY 2025≈$1.2B (April) “Approach $1B” (Nov) Lowered vs April view
Q3 Adjusted EPSQ3 2025≈$1.25 (set July 31) Actual $1.14 Miss vs prior guide
Cost Reductions (net of inflation)FY 2025≈$75M target (raised in April) “> $75M” on track Maintained/affirmed
Cost Reductions (net of inflation)FY 2026—≈$100M incremental New target articulated
DividendQuarterly—$0.83 per share (declared Aug 7) Maintained payout cadence

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 2025, Q2 2025)Current Period (Q3 2025)Trend
Circular platform (methanolysis/ARPET)Best-ever uptime; production records; disciplined approach to second facility 90% yields; feasible ~30% capacity bottleneck; “meaningful” EBITDA increase expected; ARPET demand/commitments; Pepsi volume pulled forward Accelerating execution
Cost actionsRaised net savings target to ~$75M; focus on cash and cost 2025 net savings >$75M; add ~$100M in 2026; 7% headcount reduction; AI-enabled productivity discussed Increasing
Tariffs / inventory prepositionTariff uncertainty; supply chain adjustments Customers unwinding H1 pre-buy, pressuring Q3/Q4; greater-than-normal seasonality Persistent headwind near-term
Demand in consumer discretionaryWeak end markets; cautious customers AM/Fibers pressured; aftermarket weakening; management sees Q1 snap-back potential post destock Near-term weak; early signs of relief
Chemical Intermediates spreadsQ2 outage, lower spreads Spreads remain challenged; tariffs protect NA margins; 2026 better with demand recovery/rationalization Stabilizing at low levels
Fibers/textilesDestocking; China trade dispute impact Tow destock persists; textiles hurt by tariffs; expect stabilization into next year Cyclical pressure persists

Management Commentary

  • “We delivered strong cash flow in the third quarter with our inventory actions and aggressive cost management.”
  • “We expect a modest increase in revenue from the Kingsport methanolysis facility.”
  • “We believe that 30% expansion of the capacity is very feasible... we’ve hit 90% yields” at Kingsport methanolysis .
  • “Best way to think about building a base case for next year... $50–$75M utilization tailwind and ~$100M net cost reduction” depending on volumes .
  • “Pepsi... baseload contract... restructuring... to move that volume into next year” with supply from Kingsport and flexible polymer lines .

Q&A Highlights

  • 2026 earnings bridge: Management frames a base using FY25 volumes (AM down ~4%, AFP down ~2%), adds ~$50–$75M utilization tailwind and ~$100M net 2026 cost saves, plus circular platform EBITDA uplift .
  • Circular capacity and yields: Kingsport achieving ~90% yields; feasible ~30% capacity uplift via bottlenecking with modest capex; ARPET/customer commitments providing revenue step-up .
  • Pepsi contract: Restructured to pull forward ARPET volume; management confident it can supply from Kingsport and reconfigured lines .
  • CI outlook: Spreads pressured by Chinese capacity and weak exports; tariffs help NA margins; potential improvement with housing/durables recovery and higher volumes next year .
  • Cost and AI: 7% headcount reduction embedded in >$75M 2025 net savings; ~$100M 2026 target; AI to enhance commercial offers, manufacturing reliability, and innovation productivity .

Estimates Context

  • Q3 2025 vs S&P Global consensus: Revenue $2.202B vs $2.275B* (miss ~3.3%); Adjusted EPS $1.14 vs $1.165* (slight miss ~$0.03); EBITDA $342M* vs $338.3M* (slight beat) (11 revenue estimates, 15 EPS estimates) .
  • Implications: Modest shortfall in revenue/EPS driven by weaker volumes and deliberate underutilization to drive cash; Street models may trim near-term run-rate, but circular ramp, inventory normalization into Q1, and cost-down actions support outer-quarter estimate stability .

Values marked with * retrieved from S&P Global.

Key Takeaways for Investors

  • Near-term softness largely volume-driven and macro/tariff-related; management prioritized cash, delivering $402M OCF with ~$204M inventory release in Q3 .
  • Specialty pricing holds; AFP margin resilience (17.9% adj. EBIT margin) underscores pricing power even as volumes dip .
  • Circular platform is an increasingly material EBITDA driver for 2026: 90% yields, feasible ~30% debottleneck, ARPET commitments (including Pepsi) pulled forward .
  • FY25 outlook reframed: Adjusted EPS $5.40–$5.65 and OCF “approach $1B”; watch Q4 destock progress and Q1 seasonal rebound .
  • Cost program intensifying: >$75M net in 2025 and ~$100M in 2026, plus AI-enabled productivity—supports margin recovery as volumes stabilize .
  • Segment watchlist: AM and Fibers exposed to consumer discretionary and China textiles; CI mix/spreads remain challenged but could improve with NA housing/durables and rationalization .
  • Capital returns steady: $146M returned in Q3; $0.83/qtr dividend declared (paid Oct 7), with management confidence in dividend sustainability .

Notes:

  • All company figures and commentary are sourced from EMN’s Q3 2025 8‑K and press releases, and earnings call transcript as cited. Consensus and EBITDA values marked with * are retrieved from S&P Global.